The Latest in CLL

CLL treatment: More infections among real-world patients

March 6, 2023

Surviving CLL: Higher risk of other cancer DXs

February 17, 2023

CLL

Despite limits, COVID vaccines protect CLL patients

February 6, 2023

CLL

Adding venetoclax improves ibrutinib outcomes in CLL

January 23, 2023

CLL

CLL phase 3 study: Zanubrutinib bests ibrutinib

December 16, 2022

CLL

High cost and demand for old cancer drug sparks crisis

December 5, 2022

FDA approved acalabrutinib tablet for MCL, CLL, SLL

October 19, 2022

CAR T-cell therapy neurotoxicity linked to NfL elevations

October 3, 2022

‘Molecular map’ of CLL yields fresh genetic insights

August 29, 2022

CLL

First drug therapy approved for childhood GVHD

August 26, 2022

Young children with leukemia are outliving teens

August 24, 2022

CLL

Where women’s voices still get heard less

August 18, 2022

CLL

Phase 3 data: Zanubrutinib bests standard CLL treatment

August 16, 2022

Many die waiting for `last-chance’ therapy

August 2, 2022

CLL

CAR T-cell therapy turns 10 and finally earns the word ‘cure’

July 22, 2022

CLL